Erratum to: Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis (BioDrugs, 10.1007/s40259-016-0190-5)

Abstract

Page 5, column 2, section 4.1, paragraph 2, line 25: The following dosage, which previously read “3 or 5 mg BID” should read “5 or 10 mg BID”. Page 6, table 4, ‘ORAL-standard phase III’ study, ‘Intervention’ column: 2nd row, which previously read “MTX + Tofa 3 mg BID” should read “MTX + Tofa 5 mg BID” 3rd row, which previously read “MTX + Tofa 5 mg BID” should read “MTX + Tofa 10 mg BID.”